2025 Annual Report
Annual Report
ECETOC publishes a framework for the risk assessment of plastic additives
Press Release

ECETOC publishes a framework for the risk assessment of plastic additives

Part 1 sets out the fundamental elements, from problem formulation to risk characterisation.Brussels, 22 July 2026. The ECETOC Plastic Additives Task Force has published the first of two peer...
January 2026 news from the Sec Gen
News

January 2026 news from the Sec Gen

Dear colleagues and friends,As we begin a new year, I would like to thank you for your continued engagement and trust in ECETOC. 2026 promises to be an exciting and dynamic year, and I am pleased...
HSSD Tool

HSSD Tool

This software was developed by a consortium of partners to facilitate the uptake of novel approaches to estimate aquatic threshold concentrations (e.g. the concentration at which 5% of the species are exposed above their EC50, HC5).
The Human Exposure Assessment Tools Database (heatDB)

The Human Exposure Assessment Tools Database (heatDB)

heatdb is a public directory of exposure data sources as well as available tools for exposure
NanoApp

NanoApp

ECETOC’s NanoApp is a tool designed to define the boundaries of sets of similar nanoforms and to generate a justification for the REACH registration.
Targeted Risk Assessment (TRA)

Targeted Risk Assessment (TRA)

The Targeted Risk Assessment (TRA) estimates exposures to workers, consumers and the environment that arise during a series of events.
Chronic fish case studies towards an IATA

Chronic fish case studies towards an IATA

Why?Hazard and safety assessments for the pelagic compartment often rely on in vivo studies using a single fish species, raising ethical concerns and uncertainty in terms of extrapolation....
Estimating the environmental release of Synthetic Polymeric Microparticles from Products

Estimating the environmental release of Synthetic Polymeric Microparticles from Products

Why?REACH restriction: SPM use restricted; emissions reporting required by May 2027. Gap: No analytical methods available to measure SPM emissions. Solution: Draft SPERC-based approac...
Case Studies on Reliability and Relevance Considerations during Validation of NAMs

Case Studies on Reliability and Relevance Considerations during Validation of NAMs

Why?Validation of NAMs is often overlooked despite its importance for regulatory use. Traditional validation methods are less suitable for NAMs, which focus on key events rather than apical...
Technical Report
30.08.1995

TR 065 – Formaldehyde and Human Cancer Risks

TR 065 : Formaldehyde and Human Cancer Risks | May 1995

Formaldehyde is a natural component in all mammalian cells and because of active enzymatic pathways is rapidly detoxified. Its use by man has been long-term and widespread, finding both medical and industrial applications.

This review examines the cytologic and cytogenetic studies of workers exposed to formaldehyde and examines the epidemiologic studies on cancer risk as they relate to formaldehyde exposure. All studies reviewed were non-experimental in design and as such concerns of bias, confounding and chance must be evaluated thoroughly before any etiologic conclusion can be drawn.

The cytologic and cytogenetic studies of worker volunteers in the formaldehyde industry were inconsistent in their findings, biased in their selection of exposed and non-exposed control subjects, confounded by other exposures and not large enough to allow for the sufficient exclusion of chance. Before these studies can be taken as serious evidence they must be larger in scale, show absence of selection bias and provide proper control of confounding factors and present a detailed and informed analysis.

Epidemiologic studies of formaldehyde and human cancer risk can be divided into three major groups: formaldehyde industry workers, morticians and medical professionals, and community-based case-control studies. These three groups reflect a descending order in the likelihood of exposure, with the formaldehyde industry workers having certain, and for the most part, measured exposure. The medical professionals and morticians are likely to have some exposure with the potential for short-term high peaks in exposure. Community-based case-control studies have no certainty of exposure; all putative exposure to formaldehyde is inferred from job titles.

The cohort studies of formaldehyde industry workers provide no convincing evidence of a link with cancer. There is no evidence of an excess of nasal cancer, the neoplasm reported in animal studies. One study suggesting an association between formaldehyde and nasopharyngeal cancer has been shown to suffer from misdiagnosis and multiple comparison biases.

Studies of medical professionals and morticians report no link with nasal cancer, nasopharyngeal or lung cancer risk, sites that would come into contact with formaldehyde. Based on years of animal experiments, effects on sites distal to those exposed are not considered to be related to formaldehyde due to the highly reactive nature and rapid metabolism of this chemical. Hence the excess of colon and brain cancer and leukaemia found among professionals is not likely to be a result of their exposure to formaldehyde.

Community-based case-control studies provide the weakest evidence of all study approaches because there is no documented exposure, data for the latter is derived from job-titles. In this context it is worth noting that the case-control studies performed within cohorts of formaldehyde industry workers (nested case-control studies) were all uniform in showing no relation to formaldehyde exposure. The community-based studies failed to eliminate bias, confounding and chance as the most likely explanations of their findings. None provides convincing evidence of a causal link.

After a careful review of the cytologic, cytogenic and epidemiological studies there is an absence of evidence to support the judgement of an etiologic relationship between formaldehyde and human cancer risk. Causal criteria used by epidemiologists in evaluating an association, such as strength of an association, consistency of results across studies, dose-response effects, biologic plausibility and coherence have not been met by the studies examined in this report.